Asia Pacific Direct-To-Consumer Laboratory Testing Market Size is USD 909.68 Million in 2026

Asia Pacific Direct-To-Consumer Laboratory Testing Market (By Product: Medical Genetic Laboratory Testing, Routine Clinical Laboratory Testing; By Test Type; By Sample Type: Blood, Urine, Saliva, Others) Industry Size, Share, Growth, Trends 2026 to 2035.

Report Code : 570 | Published : 08 May 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 83 Mn

Forecast Year,

USD 2,075.79 Mn

CAGR, 2026 - 2035

9.60%

Report Coverage

Asia Pacific

Download Databook

The Asia Pacific direct-to-consumer laboratory testing market is projected to grow from USD 830 million in 2025 to around USD 2.08 billion by 2035, with a CAGR of 9.60%. This growth is driven by rising consumer demand for accessible, at-home testing solutions and advancements in healthcare technology in the region.

Asia Pacific Direct-To-Consumer Laboratory Testing Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 830 Million
Market Size in 2026	USD 909.68 Million
Market Size by 2035	USD 2,075.79 Million
CAGR 2026 to 2035	9.60%
Base Year	2025
Forecast Period	2026 to 2035

In the Asia Pacific region, direct-to-consumer laboratory testing is becoming a vibrant growth market, propelled by expanding healthcare infrastructure, a rising disease burden, and an increasing adoption of precision diagnostics . Rapid urbanization, a growing middle class, and government initiatives to enhance molecular testing capacity are accelerating market penetration. Countries like China, India, Japan, and South Korea are witnessing substantial investments in genomics and biopharmaceutical research. Local laboratories are creating cost-effective and customized LDTs tailored to their specific regional disease profiles.

Segments	Shares (%)
Medical genetic laboratory testing	55%
Routine clinical laboratory testing	45%

Routine clinical laboratory testing- Routine clinical laboratory testing dominates the market, with a share of 55%, driven by increasing demand for affordable and accessible routine health check-ups across a large population base.
Medical genetic laboratory testing- Medical genetic laboratory testing holds a significant share of 45% of the market, supported by growing awareness of personalized medicine.

Segments	Shares (%)
Genetic testing	21%
Cancer testing	18%
Routine testing	19%
Diabetes testing	12%
COVID-19	8%
Disease Risk Assessment Testing	13%
Sexually Transmitted Disease Testing	9%

Genetic testing- Genetic testing leads the market with a share of 21%, driven by rising interest in personalized health insights and early disease risk detection.
Routine testing- Routine testing holds a strong share of 19% of the market, supported by increasing demand for regular health monitoring and preventive care.
Cancer testing- Cancer testing accounts for 18% of the market, driven by growing awareness and the need for early diagnosis.
Diabetes testing- Diabetes testing holds 12% of the market, supported by the increasing prevalence of diabetes across the region.

Segments	Shares (%)
Blood	45%
Saliva	25%
Urine	20%
Others	10%

Blood- Blood-based testing dominates the market, with a share of 45%, driven by its high accuracy and wide applicability across multiple test types.
Saliva- Saliva-based testing holds a share of 25% of the market, supported by its non-invasive nature and growing use in genetic testing.
Urine- Urine-based testing accounts for 20% of the market, driven by ease of collection and use in routine diagnostics.

Top Companies in the Asia Pacific Direct-To-Consumer Laboratory Testing Market

Any Lab Test Now, Inc.
Color Genomics, Inc
Counsyl, Inc.
DanteLabs Inc.
Direct Laboratory Services, LLC
Eastern Biotech & Life Sciences
EasyDNA
EverlyWell, Inc.,
Full Genomes Corporation, Inc.
Gene by Gene, Ltd.
Genecodebook Oy
Genesis Healthcare Co.
Genetrainer
GHC Genetics UK
HealthCheckUSA
Home Access Health Corporation
International Biosciences
Laboratory Corporation of America Holdings
LetsGetChecked, Inc.
Mapmygenome India Limited

Segments Covered in the Report

By Product

Medical Genetic Laboratory Testing
Routine Clinical Laboratory Testing

By Test Type

Genetic Testing
Cancer
Diabetes Testing
Disease Risk Assessment Testing
COVID-19
Sexually Transmitted Disease Testing
Routine Testing

By Sample Type

Blood
Urine
Saliva
Others

List of Tables & Figures

List of Tables

Table 1: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size, 2025-2035 (USD Million)
Table 2: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size, by Product, 2025-2035 (USD Million)
Table 3: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size, by Test Type, 2025-2035 (USD Million)
Table 4: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size, by Sample Type, 2025-2035 (USD Million)
Table 5: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Medical Genetic Laboratory Testing, 2025-2035 (USD Million)
Table 6: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Routine Clinical Laboratory Testing, 2025-2035 (USD Million)
Table 7: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Genetic Testing, 2025-2035 (USD Million)
Table 8: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - COVID-19 Testing, 2025-2035 (USD Million)
Table 9: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Cancer Testing, 2025-2035 (USD Million)
Table 10: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Diabetes Testing, 2025-2035 (USD Million)
Table 11: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Disease Risk Assessment Testing, 2025-2035 (USD Million)
Table 12: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Sexually Transmitted Disease Testing, 2025-2035 (USD Million)
Table 13: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Routine Testing, 2025-2035 (USD Million)
Table 14: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Complete Blood Count Testing, 2025-2035 (USD Million)
Table 15: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - CNS-related/Neurological Disease Testing, 2025-2035 (USD Million)
Table 16: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Thyroid Stimulating Hormone Testing, 2025-2035 (USD Million)
Table 17: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Other Testing, 2025-2035 (USD Million)
Table 18: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Blood Sample Testing, 2025-2035 (USD Million)
Table 19: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Urine Sample Testing, 2025-2035 (USD Million)
Table 20: Asia Pacific Direct-To-Consumer Laboratory Testing Market Size - Saliva Sample Testing, 2025-2035 (USD Million)

List of Figures

Figure 1: Asia Pacific Direct-To-Consumer Laboratory Testing Market Forecast, 2025-2035 (USD Million)
Figure 2: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by Product, 2025 (%)
Figure 3: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by Test Type, 2025 (%)
Figure 4: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by Sample Type, 2025 (%)
Figure 5: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by Medical Genetic Laboratory Testing, 2025 (%)
Figure 6: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by Routine Clinical Laboratory Testing, 2025 (%)
Figure 7: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by Genetic Testing, 2025 (%)
Figure 8: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by COVID-19 Testing, 2025 (%)
Figure 9: Asia Pacific Direct-To-Consumer Laboratory Testing Market Share, by Cancer Testing, 2025 (%)
Figure 10: Asia Pacific Direct-To-Consumer Laboratory Testing Market Growth Opportunity Map, 2025-2035 (% CAGR)

Research Methodology

Related Databooks

March 2026